(Total Views: 531)
Posted On: 12/09/2022 1:12:55 PM
Post# of 153864
Quote:
Neurimmune is a biopharmaceutical company translating human immune memory into antibody therapeutics. Neurimmune scientists discovered aducanumab together with a team of researchers at the University of Zurich. Neurimmune licensed aducanumab to Biogen and collaborates with Biogen on its development. In 2021, the U.S. FDA approved aducanumab for the treatment of Alzheimer’s disease.
These are the folks that brought is aducanumab. The one no one at FDA voted to approve, but it got approved in spite of the vote.
Neurimmune is a biopharmaceutical company translating human immune memory into antibody therapeutics. Neurimmune scientists discovered aducanumab together with a team of researchers at the University of Zurich. Neurimmune licensed aducanumab to Biogen and collaborates with Biogen on its development. In 2021, the U.S. FDA approved aducanumab for the treatment of Alzheimer’s disease.
These are the folks that brought is aducanumab. The one no one at FDA voted to approve, but it got approved in spite of the vote.
(2)
(1)
